ATAGI have recommended COVID-19 booster doses for some groups of 5-11 year olds who have previously completed a primary course of COVID-19 vaccination. Eligible groups include those with severe immunocompromise, a disability with significant or complex health needs, or those with complex/multiple health conditions that increase the risk of severe COVID-19 disease. 

Boosters in this age group can be administered 3 or more months after completing a primary course of COVID-19 vaccines. An interval of 3 months between COVID-19 infection and COVID vaccines is recommended.  

There is currently not enough evidence to support booster doses for other groups of 5-11 year olds, however recommendations may change as more evidence emerges. All children in this age group are recommended to receive a primary course of COVID-19 vaccination.  

To read the recommendations in full please follow the link below.

ATAGI recommendations for a booster dose of the paediatric Pfizer COVID-19 vaccine in children aged 5 to 11 years.

MVEC acknowledges the traditional owners of the lands on which we live, work and educate. We pay our respects to their Elders, past, present and emerging.
We are committed to honouring Australian Aboriginal and Torres Strait Islander peoples’ unique cultural and spiritual relationships to the land, waters and seas.

关于 MVEC

墨尔本疫苗教育中心 (MVEC) 是一个教育网站,旨在为医疗保健专业人员和公众提供最新的免疫接种信息。我们位于研究机构默多克儿童研究所 (MCRI),隶属于维多利亚疫苗安全服务机构 SAEFVIC(社区接种疫苗后的不良事件监测)。

分享这个